Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence.

International Urogynecology Journal and Pelvic Floor Dysfunction
Chi Chiung Grace ChenMatthew D Barber

Abstract

The aim of this study was to correlate the lowest Valsalva or cough leak point pressure (LPP) with clinical measures of incontinence severity and quality of life in women with pure urodynamic stress incontinence (SUI). This is an analysis of the baseline data from a prospective, multicenter, randomized trial comparing the Monarc transobturator sling to the tension-free vaginal tape. One hundred fifty-five women with SUI underwent urodynamic evaluations including abdominal or vesical LPP determinations, and each completed the Sandvik Incontinence Severity Index, a 3-day voiding diary, and quality-of-life questionnaires. In patients with a LPP, there were no significant correlations between LPP and the above clinical measures of incontinence severity or condition-specific quality-of-life questionnaire scores. In this patient population with pure urodynamic SUI, LPP is not a useful urodynamic predictor of baseline SUI severity and its effects on quality of life.

References

Aug 1, 1992·The Journal of Urology·R M Decter, L Harpster
Jun 1, 1991·The Journal of Urology·J G Blaivas, B Z Jacobs
Jun 1, 1987·British Journal of Urology·H Al-TaherM C Brown
Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S A ShumakerJ A Fantl
Aug 1, 1993·The Journal of Urology·J WanM L Ritchey
Nov 1, 1993·The Journal of Urology·E J McGuireE A Gormley
Jul 1, 1996·American Journal of Obstetrics and Gynecology·R C BumpA R Smith
Jan 1, 1996·International Urogynecology Journal and Pelvic Floor Dysfunction·H SiltbergA Victor
Mar 1, 1997·The Journal of Urology·J M CummingsJ Wozniak-Petrofsky
Mar 22, 2000·Obstetrics and Gynecology·D HowardJ A Ashton-Miller
Nov 9, 2000·Neurourology and Urodynamics·U M PeschersT Dimpfl
Apr 11, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·G C HsiehW H Kobak
May 5, 2001·BMJ : British Medical Journal·J HanleyS Hagen
Jan 25, 2002·International Urogynecology Journal and Pelvic Floor Dysfunction·C W NagerA Monga
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Apr 12, 2002·Neurourology and Urodynamics·Werner SchäferUNKNOWN International Continence Society
Sep 5, 2003·International Urogynecology Journal and Pelvic Floor Dysfunction·Rebecca G RogersClifford Qualls
Oct 7, 2004·Neurourology and Urodynamics·Jae-Seung PaickSoo Woong Kim
Nov 15, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Andrew F HundleyAnthony G Visco
May 16, 2006·The Journal of Urology·P ZimmernUNKNOWN Urinary Incontinence Treatment Network
Apr 18, 2007·The Journal of Urology·Michael AlboUNKNOWN Urinary Incontinence Treatment Network

❮ Previous
Next ❯

Citations

Feb 6, 2010·International Urogynecology Journal·Jenn-Ming YangChii-Ruey Tzeng
Feb 11, 2010·International Urogynecology Journal·Artur RogowskiWlodzimierz Baranowski
Nov 1, 2008·Neurourology and Urodynamics·Alexandra L HaesslerNarender N Bhatia
Feb 4, 2010·Neurourology and Urodynamics·Charles W NagerUNKNOWN Urinary Incontinence Treatment Network
Sep 6, 2014·Actas urologicas españolas·J P ValdevenitoJ P Díaz
Aug 2, 2017·The Cochrane Database of Systematic Reviews·Abigail A FordJoseph A Ogah
Mar 5, 2021·International Urogynecology Journal·Linda McLeanRobert Brison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.